Head of Investor Relations, AstraZeneca
Thomas Kudsk Larsen is Head of Investor Relations (IR) at AstraZenenca since 1 October 2014. Thomas leads the IR Team consisting of currently 8 people and is responsible for investor and analyst interactions. Thomas joined AstraZeneca from Roche where he was Head of Investor Relations North America since 2005 and Vice President, Roche Holdings, Inc. based at Genentech, Inc. in South San Francisco, USA.
From 2004-2005, Thomas was Manager of Stakeholder Communications, Novozymes North America, North Carolina, USA and from 2001-2004 Manager, Investor Relations, Novozymes, a Danish industrial biotech company. From 2000-2001, Thomas was Financial analyst, Novo Nordisk Pharma, Tokyo, Japan and 1995-2000 worked in various Finance positions at Novo Nordisk, Denmark.
Thomas holds HD Finance from Copenhagen Business School and is a Danish citizen. Thomas lives in Trumpington, Cambridge, UK with a family; wife and two daughters.